The MerR-like regulator BrlR impairs Pseudomonas aeruginosa biofilm tolerance to colistin by repressing PhoPQ

Journal of Bacteriology

Volumn 195, Issue 20, 2013, Pages 4678-4688

  Chambers, Jacob R ^a   Sauer, Karin ^a  

^a BINGHAMTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRLR PROTEIN; COLISTIN; MERR PROTEIN; PHOPQ PROTEIN; REGULATOR PROTEIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BIOFILM; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE OVEREXPRESSION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPERON; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; WILD TYPE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BIOFILMS; COLISTIN; DOWN-REGULATION; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MULTIGENE FAMILY; PSEUDOMONAS AERUGINOSA; TOBRAMYCIN;

EID: 84885746524     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00834-13     Document Type: Article

References (60)

1. Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193.
2. Wagner VE, Iglewski BH. 2008. P. aeruginosa biofilms in CF infection. Clin. Rev. Allergy Immunol. 35:124-134.
3. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. 1995. Microbial biofilms. Annu. Rev. Microbiol. 49:711-745.
4. Davey ME, O'Toole GA. 2000. Microbial biofilms: from ecology to molecular genetics. Microbiol. Mol. Biol. Rev. 64:847-867.
5. Parsek MR, Singh PK. 2003. Bacterial biofilms: an emerging link to disease pathogenesis. Annu. Rev. Microbiol. 57:677-701.
6. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
7. Stewart PS, Costerton JW. 2001. Antibiotic resistance of bacteria in biofilms. Lancet 358:135-138.
8. Drenkard E. 2003. Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microbes Infect. 5:1213-1219.
9. Gilbert P, Collier PJ, Brown MR. 1990. Influence of growth rate on susceptibility to antimicrobial agents: biofilms, cell cycle, dormancy, and stringent response. Antimicrob. Agents Chemother. 10:1865-1868.
10. Anwar H, Strap JL, Chen K, Costerton JW. 1992. Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin. Antimicrob. Agents Chemother. 36:1208-1214.
11. Anderl JN, Zahller J, Roe F, Stewart PS. 2003. Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob. Agents Chemother. 47: 1251-1256.
12. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. 2004. Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 230:13-18.
13. Campanac C, Pineau L, Payard A, Baziard-Mouysset G, Roques C. 2002. Interactions between biocide cationic agents and bacterial biofilms. Antimicrob. Agents Chemother. 46:1469-1474.
14. Anderl JN, Franklin MJ, Stewart PS. 2000. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob. Agents Chemother. 44:1818-1824.
15. Nguyen D, Joshi-Datar A, Lepine F, Bauerle E, Olakanmi O, Beer K, McKay G, Siehnel R, Schafhauser J, Wang Y, Britigan BE, Singh PK. 2011. Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 334:982-986.
16. Connell JL, Wessel AK, Parsek MR, Ellington AD, Whiteley M, Shear JB. 2010. Probing prokaryotic social behaviors with bacterial "lobster traps". mBio 1:e00202-10. doi:10.1128/mBio.00202-10.
17. Liao J, Sauer K. 2012. The MerR-like transcriptional regulator BrlR contributes to Pseudomonas aeruginosa biofilm tolerance. J. Bacteriol. 194: 4823-4836.
18. Liao J, Schurr MJ, Sauer K. 2013. The MerR-like regulator BrlR confers biofilm tolerance by activating multidrug-efflux pumps in Pseudomonas aeruginosa biofilms. J. Bacteriol. 195:3352-3363.
19. Masuda N, Sakagawa E, Ohya S, Gotoh N, Tsujimoto H, Nishino T. 2000. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44:3322-3327.
20. Hancock RE, Rozek A. 2002. Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol. Lett. 206:143-149.
21. Hancock R. 1997. Peptide antibiotics. Lancet 349:418-422.
22. Matsuzaki K, Yoneyama S, Fujii N, Miyajima K, Yamada K-I, Kirino Y, Anzai K. 1997. Membrane permeabilization mechanisms of a cyclic antimicrobial peptide, tachyplesin I, and its linear analog. Biochemistry 36: 9799-9806.
23. Matsuzaki K, Sugishita K, Harada M, Fujii N, Miyajima K. 1997. Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. Biochim. Biophys. Acta 1327: 119-130.
24. Falagas ME, Kasiakou SK, Saravolatz LD. 2005. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis. 40:1333-1341.
25. Macfarlane ELA, Kwasnicka A, Ochs MM, Hancock REW. 1999. PhoPPhoQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistance. Mol. Microbiol. 34:305-316.
26. McPhee JB, Bains M, Winsor G, Lewenza S, Kwasnicka A, Brazas MD, Brinkman FSL, Hancock REW. 2006. Contribution of the PhoP-PhoQ and PmrA-PmrB two-component regulatory systems to Mg2+-induced gene regulation in Pseudomonas aeruginosa. J. Bacteriol. 188:3995-4006.
27. Moskowitz S, Ernst R, Miller S. 2004. PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J. Bacteriol. 186:575-579.
28. Fernández L, Jenssen H, Bains M, Wiegand I, Gooderham WJ, Hancock REW. 2012. The two-component system CprRS senses cationic peptides and triggers adaptive resistance in Pseudomonas aeruginosa independently of ParRS. Antimicrob. Agents Chemother. 56:6212-6222.
29. Fernández L, Gooderham WJ, Bains M, McPhee JB, Wiegand I, Hancock REW. 2010. Adaptive resistance to the "Last Hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS. Antimicrob. Agents Chemother. 54:3372-3382.
30. Schweizer HP. 1991. The agmR gene, an environmentally responsive gene, complements defective glpR, which encodes the putative activator for glycerol metabolism in Pseudomonas aeruginosa. J. Bacteriol. 173: 6798-6806.
31. Newman JR, Fuqua C. 1999. Broad-host-range expression vectors that carry the arabinose-inducible Escherichia coli araBAD promoter and the araC regulator. Gene 227:197-203.
32. Kaneko Y, Thoendel M, Olakanmi O, Britigan BE, Singh PK. 2007. The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. J. Clin. Invest. 117: 877-888.
33. Andrews JM. 2001. Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother. 48:5-16.
34. Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG. 2002. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J. Bacteriol. 184:1140-1154.
35. Sauer K, Cullen MC, Rickard AH, Zeef LAH, Davies DG, Gilbert P. 2004. Characterization of nutrient-induced dispersion in Pseudomonas aeruginosa PAO1 biofilm. J. Bacteriol. 186:7312-7326.
36. Petrova OE, Sauer K. 2009. A novel signaling network essential for regulating Pseudomonas aeruginosa biofilm development. PLoS Pathog. 5:e1000668. doi:10.1371/journal.ppat.1000668.
37. Frank KL, Reichert EJ, Piper KE, Patel R. 2007. In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates. Antimicrob. Agents Chemother. 51:888-895.
38. Zhang L, Mah T-F. 2008. Involvement of a novel efflux system in biofilmspecific resistance to antibiotics. J. Bacteriol. 190:4447-4452.
39. Sauer K, Camper AK. 2001. Characterization of phenotypic changes in Pseudomonas putida in response to surface-associated growth. J. Bacteriol. 183:6579-6589.
40. Allegrucci M, Sauer K. 2007. Characterization of colony morphology variants isolated from Streptococcus pneumoniae biofilms. J. Bacteriol. 189: 2030-2038.
41. Allegrucci M, Sauer K. 2008. Formation of Streptococcus pneumoniae non-phase-variable colony variants is due to increased mutation frequency present under biofilm growth conditions. J. Bacteriol. 190:6330-6339.
42. Southey-Pillig CJ, Davies DG, Sauer K. 2005. Characterization of temporal protein production in Pseudomonas aeruginosa biofilms. J. Bacteriol. 187:8114-8126.
43. McBain AJ, Bartolo RG, Catrenich CE, Charbonneau D, Ledder RG, Rickard AH, Symmons SA, Gilbert P. 2003. Microbial characterization of biofilms in domestic drains and the establishment of stable biofilm microcosms. Appl. Environ. Microbiol. 69:177-185.
44. Petrova OE, Sauer K. 2010. The novel two-component regulatory system BfiSR regulates biofilm development by controlling the small RNA rsmZ through CafA. J. Bacteriol. 192:5275-5288.
45. McPhee JB, Lewenza S, Hancock REW. 2003. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol. Microbiol. 50:205-217.
46. Mulcahy H, Charron-Mazenod L, Lewenza S. 2008. Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS Pathog. 4:e1000213. doi:10.1371/journal.ppat.1000213.
47. Wurtzel O, Yoder-Himes DR, Han K, Dandekar AA, Edelheit S, Greenberg EP, Sorek R, Lory S. 2012. The single-nucleotide resolution transcriptome of Pseudomonas aeruginosa grown in body temperature. PLoS Pathog. 8:e1002945. doi:10.1371/journal.ppat.1002945.
48. Macfarlane ELA, Kwasnicka A, Hancock REW. 2000. Role of Pseudomonas aeruginosa PhoP-PhoQ in resistance to antimicrobial cationic peptides and aminoglycosides. Microbiology 146:2543-2554.
49. Nicas TI, Hancock RE. 1980. Outer membrane protein H1 of Pseudomonas aeruginosa: involvement in adaptive and mutational resistance to ethylenediaminetetraacetate, polymyxin B, and gentamicin. J. Bacteriol. 143: 872-878.
50. Ogle JW, Janda JM, Woods DE, Vasil ML. 1987. Characterization and use of aDNAprobe as an epidemiological marker for Pseudomonas aeruginosa. J. Infect. Dis. 155:119-126.
51. Struelens MJ, Schwam V, Deplano A, Baran D. 1993. Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients. J. Clin. Microbiol. 31:2320-2326.
52. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D'Argenio DA, Miller SI, Ramsey BW, Speert DP, Moskowitz SM, Burns JL, Kaul R, Olson MV. 2006. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc. Natl. Acad. Sci. U. S. A. 103:8487-8492.
53. Wolz C, Kiosz G, Ogle JW, Vasil ML, Schaad U, Botzenhart K, Döring G. 1989. Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe. Epidemiol. Infect. 102: 205-214.
54. Huse HK, Kwon T, Zlosnik JEA, Speert DP, Marcotte EM, Whiteley M. 2010. Parallel evolution in Pseudomonas aeruginosa over 39,000 generations in vivo. mBio 1(4):e00199-10. doi:10.1128/mBio.00199-10.
55. Monsieurs P, De Keersmaecker S, Navarre WW, Bader MW, De Smet F, McClelland M, Fang FC, De Moor B, Vanderleyden J, Marchal K. 2005. Comparison of the PhoPQ regulon in Escherichia coli and Salmonella typhimurium. J. Mol. Evol. 60:462-474.
56. Soncini FC, Groisman EA. 1996. Two-component regulatory systems can interact to process multiple environmental signals. J. Bacteriol. 178:6796-6801.
57. Poole K. 2011. Pseudomonas aeruginosa: resistance to the max. Front. Microbiol. 2:65.
58. Herrmann G, Yang L, Wu H, Song Z, Wang H, Høiby N, Ulrich M, Molin S, Riethmüller J, Döring G. 2010. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa. J. Infect. Dis. 202:1585-1592.
59. Jacobs MA, Alwood A, Thaipisuttikul I, Spencer D, Haugen E, Ernst S, Will O, Kaul R, Raymond C, Levy R, Chun-Rong L, Guenthner D, Bovee D, Olson MV, Manoil C. 2003. Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. U. S. A. 100:14339-14344.
60. Petrova OE, Sauer K. 2012. PAS domain residues and prosthetic group involved in BdlA-dependent dispersion response by Pseudomonas aeruginosa biofilms. J. Bacteriol. 194:5817-5828.